Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse

NCT01953432 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01953432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01953432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
April 1, 2014
Completion date
October 1, 2017
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine dependence